These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 22837197)
41. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant. Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188 [TBL] [Abstract][Full Text] [Related]
42. Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains. Kim JH; Liepkalns J; Reber AJ; Lu X; Music N; Jacob J; Sambhara S Vaccine; 2016 Jan; 34(4):495-502. PubMed ID: 26706277 [TBL] [Abstract][Full Text] [Related]
43. Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets. Han HJ; Song MS; Park SJ; Byun HY; Robles NJC; Ha SH; Choi YK J Microbiol; 2019 Feb; 57(2):163-169. PubMed ID: 30706345 [TBL] [Abstract][Full Text] [Related]
44. Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection. Asahi-Ozaki Y; Itamura S; Ichinohe T; Strong P; Tamura S; Takahashi H; Sawa H; Moriyama M; Tashiro M; Sata T; Kurata T; Hasegawa H Microbes Infect; 2006 Oct; 8(12-13):2706-14. PubMed ID: 16968669 [TBL] [Abstract][Full Text] [Related]
45. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination. Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650 [TBL] [Abstract][Full Text] [Related]
46. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. Cox RJ; Hovden AO; Brokstad KA; Szyszko E; Madhun AS; Haaheim LR Vaccine; 2006 Nov; 24(44-46):6585-7. PubMed ID: 16839650 [TBL] [Abstract][Full Text] [Related]
47. Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice. Ruan BY; Yao Y; Wang SY; Gong XQ; Liu XM; Wang Q; Yu LX; Zhu SQ; Wang J; Shan TL; Zhou YJ; Tong W; Zheng H; Li GX; Gao F; Kong N; Yu H; Tong GZ Vet Microbiol; 2020 Jul; 246():108724. PubMed ID: 32605742 [TBL] [Abstract][Full Text] [Related]
48. Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge. Herbert AS; Heffron L; Sundick R; Roberts PC Virol J; 2009 Apr; 6():42. PubMed ID: 19393093 [TBL] [Abstract][Full Text] [Related]
49. Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice. Shibuya M; Aoshi T; Kuroda E; Yoshioka Y J Virol; 2020 Jun; 94(12):. PubMed ID: 32269125 [TBL] [Abstract][Full Text] [Related]
50. Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice. Kuah LF; Tang LH; Sutton T; Lim JH; Sin WL; Lamirande E; Subbarao K; Lau YF J Gen Virol; 2017 Feb; 98(2):155-165. PubMed ID: 27983474 [TBL] [Abstract][Full Text] [Related]
52. An R848-Conjugated Influenza Virus Vaccine Elicits Robust Immunoglobulin G to Hemagglutinin Stem in a Newborn Nonhuman Primate Model. Clemens EA; Holbrook BC; Kanekiyo M; Yewdell JW; Graham BS; Alexander-Miller MA J Infect Dis; 2021 Jul; 224(2):351-359. PubMed ID: 33245745 [TBL] [Abstract][Full Text] [Related]
53. Memory immune responses against pandemic (H1N1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying Mafa-A1*052:02. Arikata M; Itoh Y; Okamatsu M; Maeda T; Shiina T; Tanaka K; Suzuki S; Nakayama M; Sakoda Y; Ishigaki H; Takada A; Ishida H; Soda K; Pham VL; Tsuchiya H; Nakamura S; Torii R; Shimizu T; Inoko H; Ohkubo I; Kida H; Ogasawara K PLoS One; 2012; 7(5):e37220. PubMed ID: 22623997 [TBL] [Abstract][Full Text] [Related]
54. Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV). Sipo I; Knauf M; Fechner H; Poller W; Planz O; Kurth R; Norley S Vaccine; 2011 Feb; 29(8):1690-9. PubMed ID: 21195079 [TBL] [Abstract][Full Text] [Related]
55. Biological sex affects vaccine efficacy and protection against influenza in mice. Fink AL; Engle K; Ursin RL; Tang WY; Klein SL Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12477-12482. PubMed ID: 30455317 [TBL] [Abstract][Full Text] [Related]
56. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice]. Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253 [TBL] [Abstract][Full Text] [Related]
57. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants. Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604 [TBL] [Abstract][Full Text] [Related]
58. Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice. van der Lubbe JEM; Verspuij JWA; Huizingh J; Schmit-Tillemans SPR; Tolboom JTBM; Dekking LEHA; Kwaks T; Brandenburg B; Meijberg W; Zahn RC; Roozendaal R; Kuipers H Front Immunol; 2018; 9():2350. PubMed ID: 30369928 [TBL] [Abstract][Full Text] [Related]